enVVeno Medical Corporation (NASDAQ:NVNO) Director Sanjay Shrivastava Buys 5,400 Shares

enVVeno Medical Corporation (NASDAQ:NVNO - Get Free Report) Director Sanjay Shrivastava purchased 5,400 shares of the company's stock in a transaction that occurred on Tuesday, December 24th. The shares were purchased at an average cost of $2.90 per share, for a total transaction of $15,660.00. Following the completion of the transaction, the director now owns 9,288 shares in the company, valued at approximately $26,935.20. This represents a 138.89 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

enVVeno Medical Stock Up 8.5 %

NVNO stock traded up $0.24 during trading on Thursday, hitting $3.06. 429,034 shares of the company's stock traded hands, compared to its average volume of 113,650. The stock has a market capitalization of $53.66 million, a price-to-earnings ratio of -2.37 and a beta of 1.22. enVVeno Medical Corporation has a 52 week low of $2.45 and a 52 week high of $6.97. The stock has a fifty day moving average price of $3.19 and a two-hundred day moving average price of $4.31.

enVVeno Medical (NASDAQ:NVNO - Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The company reported ($0.35) earnings per share for the quarter, missing analysts' consensus estimates of ($0.33) by ($0.02). As a group, equities research analysts expect that enVVeno Medical Corporation will post -1.3 EPS for the current fiscal year.

Institutional Trading of enVVeno Medical

A number of institutional investors and hedge funds have recently made changes to their positions in NVNO. Hohimer Wealth Management LLC acquired a new position in enVVeno Medical during the 3rd quarter valued at approximately $286,000. Maven Securities LTD bought a new stake in enVVeno Medical in the third quarter valued at $295,000. Westside Investment Management Inc. boosted its holdings in shares of enVVeno Medical by 128.0% during the third quarter. Westside Investment Management Inc. now owns 88,375 shares of the company's stock valued at $297,000 after acquiring an additional 49,613 shares during the period. Corsair Capital Management L.P. bought a new position in shares of enVVeno Medical during the third quarter worth about $390,000. Finally, Geode Capital Management LLC increased its holdings in shares of enVVeno Medical by 7.8% in the 3rd quarter. Geode Capital Management LLC now owns 150,676 shares of the company's stock worth $506,000 after acquiring an additional 10,902 shares during the period. 34.71% of the stock is currently owned by institutional investors and hedge funds.

enVVeno Medical Company Profile

enVVeno Medical Corporation Nasdaq: NVNO is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).